Mapping of serotonin 5-HT4 receptor mRNA and ligand binding sites in the post-mortem human brain
- 1 April 2000
- Vol. 36 (1) , 35-46
- https://doi.org/10.1002/(sici)1098-2396(200004)36:1<35::aid-syn4>3.0.co;2-y
Abstract
The anatomical localization of 5-HT(4) receptor mRNA and 5-HT(4) receptor protein was examined in sections of post-mortem human brain by in situ hybridization histochemistry and radioligand receptor autoradiography. In the in situ hybridization study, the highest levels of 5-HT(4) receptor mRNA were found in caudate nucleus, putamen, nucleus accumbens, and in the hippocampal formation. No 5-HT(4) receptor mRNA was detected in globus pallidus and substantia nigra. For receptor autoradiography, two new and highly selective radioligands were compared: [(3)H]prucalopride, which preferentially labels the G-protein coupled fraction of receptors, and [(3)H]R116712, which labels the entire receptor population at subnanomolar concentrations. [(3)H]Prucalopride and [(3)H]R116712 binding was performed on human brain hemisphere sections. The highest densities for both radioligands were found in the basal ganglia (caudate nucleus, putamen, nucleus accumbens, globus pallidus, substantia nigra). Moderate to low densities were detected in the hippocampal formation and in the cortical mantle. Mismatches between 5-HT(4) receptor mRNA and binding sites in the globus pallidus and the substantia nigra suggested that the binding sites may be localized on axonal projections originating from the striatum. To compare densities of binding sites, concentration binding curves with [(3)H]prucalopride, [(3)H]R116712 and [(3)H]GR113808 were performed on membranes from homogenates of several human brain regions. Comparison of B(max)-values obtained with [(3)H]prucalopride and [(3)H]R116712 indicated that the G-protein coupled fraction of 5-HT(4) receptors in the substantia nigra was exceptionally high (54%) in comparison with percentages (16-27%) found in the frontal cortex, the striatum and the hippocampus. Such a high percentage (40%) of [(3)H]prucalopride vs. [(3)H]R116712 binding was also observed in the substantia nigra in the receptor autoradiography experiments. The [(3)H]prucalopride binding was GppNHp-sensitive, whereas [(3)H]R116712 and [(3)H]GR113808 was not. These data indicate that in the substantia nigra 5-HT(4) receptors are more strongly coupled to their signal transduction pathway than in other brain regions.Keywords
This publication has 36 references indexed in Scilit:
- Cloning, Expression, and Pharmacology of Four Human 5‐Hydroxytryptamine4 Receptor Isoforms Produced by Alternative Splicing in the Carboxyl TerminusJournal of Neurochemistry, 1998
- Cloning and expression of human 5-HT4S receptors. Effect of receptor density on their coupling to adenylyl cyclaseNeuroReport, 1997
- Detailed mapping of serotonin 5-HT1B and 5-HT1D receptor messenger RNA and ligand binding sites in guinea-pig brain and trigeminal ganglion: clues for functionNeuroscience, 1997
- Lesion Study of the Distribution of Serotonin 5‐HT4 Receptors in Rat Basal Ganglia and HippocampusEuropean Journal of Neuroscience, 1996
- Cloning, expression and pharmacology of the mouse 5‐HT4L receptorFEBS Letters, 1996
- 5-HT4 receptor stimulation facilitates acetylcholine release in rat frontal cortexNeuroReport, 1994
- Localization of 5-HT1B, 5-HT1Dα, 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brainNeuropharmacology, 1994
- The mouse 5-hydroxytryptamine 1B receptor is localized predominantly on axon terminalsNeuroscience, 1994
- Identification and characterization of serotonin 5-HT4 receptor binding sites in human brain: comparison with other mammalian speciesMolecular Brain Research, 1994
- A 5-HT receptor in the central nervous system, positively coupled with adenylate cyclase, is antagonized by ICS 205 930European Journal of Pharmacology, 1988